Back to Results
First PageMeta Content
Biotechnology / Pharmacy / Clinical research / Regeneron / Monoclonal antibodies / George Yancopoulos / Lexicon Pharmaceuticals / Drug discovery / Biopharmaceutical / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry


TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc
Add to Reading List

Document Date: 2015-04-07 14:06:33

Open Document

File Size: 145,74 KB

Share Result on Facebook

City

TARRYTOWN / New York / /

Company

Regeneron Pharmaceuticals Inc. / Regeneron Laboratories / Lexicon Pharmaceuticals / /

Event

Employment Change / /

Facility

University of Washington / Fred Hutchinson Cancer Research Center / University of Wisconsin / /

IndustryTerm

technology speeds / science-based biopharmaceutical / /

MedicalCondition

atopic dermatitis / rheumatoid arthritis / rare inflammatory condition / eye diseases / hypercholesterolemia / asthma / /

Organization

University of Washington / University of Wisconsin / Fred Hutchinson Cancer Research Center / /

Person

David M. Valenzuela / George D. Yancopoulos / Hires Brian Zambrowicz / Brian Zambrowicz / /

Position

Chief Scientific Officer / Vice President of Functional Genomics and Chief / President / Senior Vice President Emeritus / Genomic Technology and Innovation / Executive Vice President and Chief Scientific Officer / /

Product

VelociGene / /

ProvinceOrState

Wisconsin / New York / /

Technology

Functional Genomics / drug discovery / antibodies / drug development / /

URL

www.regeneron.com / /

SocialTag